abstract |
The present invention relates to the use and treatment of novel JNK inhibitor molecules and their use in methods of treating the human or animal body. In one aspect, the present invention provides a JNK inhibitor for use in a method of treating the human or animal body by therapy, wherein the JNK inhibitor has the general formula: X1-X2-X3-R-X4- JNK inhibitors comprising an inhibitory (poly) peptide sequence according to X5-X6-L-X7-L-X8 (SEQ ID NO: 1) and the like, wherein each X1-X8 is defined herein. |